How to interpret Revance Therapeutics Inc (RVNC)’s stock chart patterns

Within its last year performance, RVNC fell by -80.98%, with highs and lows ranging from $37.98 to $5.47, whereas the simple moving average fell by -67.31% in the last 200 days.

On January 09, 2024, Goldman Downgraded Revance Therapeutics Inc (NASDAQ: RVNC) to Neutral.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Analysis of Revance Therapeutics Inc (RVNC)

Further, the quarter-over-quarter increase in sales is 95.68%, showing a positive trend in the upcoming months.

In order to gain a clear picture of Revance Therapeutics Inc’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of -2096.78% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 4.17, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

An average volume of 1.66M can be a very valuable indicator of volatility for RVNC stock. On a monthly basis, the volatility of the stock is set at 7.89%, whereas on a weekly basis, it is put at 8.61%, with a gain of 5.42% over the past seven days. Furthermore, long-term investors anticipate a median target price of $20.64, showing growth from the present price of $6.03, which can serve as yet another indication of whether RVNC is worth investing in or should be passed over.

How Do You Analyze Revance Therapeutics Inc Shares?

In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 10.83%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 93.74% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

Are institutional investors increasing their holdings in RVNC shares?

The recent increase in stakes in RVNC appears to be a result of several institutional investors and hedge funds increasing their positions. Capital Research & Management Co’s position in RVNC has increased by 24.92% in the first quarter. The company now owns 11,960,820 shares of the stock, with a value of $105.14 million, following the purchase of 2,385,946 additional shares during the last quarter. BlackRock Fund Advisors made another increased to its shares in RVNC during the first quarter, upping its stake by 3.84%.

At the end of the first quarter, The Vanguard Group, Inc. increased its RVNC holdings by 3.05% and now holds 4.56 million RVNC shares valued at $40.1 million with the added 0.14 million shares during the period. RVNC shares are owned by institutional investors to the tune of 93.74% at present.

Related Posts